Category: Treatment

Dr. David Samadi’s SMART Career and Advice

Dr. David Samadi is a celebrity doctor and leader in prostate cancer treatment using Robotic Assisted Laparoscopic Prostatectomy. He is a certified urologist/oncologist and specialist in minimal invasive surgery and robotics.

His career accomplishments unequivocally redeem every challenge he faced in his childhood. He grew up in the Persian Jewish community of Iran and was separated from his parents after the Iranian Revolution. His education in medicine began more than 24 years ago. He is a master’s graduate in Bio Chemistry from the Stony Brook School of Medicine in the New York. He studied Urology at Montefiore Medical Center, proctology at Albert Einstein College of Medicine and Oncology at Memorial Sloan-Kettering Cancer Center.

Dr. Samadi often shares expert advice about the options men have after encountering localized prostate cancer verses a cancer that has moved beyond the prostate gland. For example, in former Republican presidential nominee Mitt Romney’s case, the leading doctor acknowledged choice of surgery as the smartest decision for the Republican’s health. Though Romney’s prostate removal surgery was performed by Dr. Thomas, Samadi endorsed Mitt’s decision to have surgical procedure for good reason.

He recommends that those men who choose to treat localized prostate cancer with surgery have higher chances of living cancer free compared to those who pick radiation. Dr. Samadi says that in cases of radiation, side effects can cause secondary cancers surrounding the treated area. He added that radiation treatment can perplex surgery in cases where prostate cancer unexpectedly returns.

Dr. Samadi knowledge and insight has named him Best Doctor across sectors. Today he has over 7,000 robotic prostate surgeries and 800 robotic laparoscopic procedures under his name with each performed using his personalized surgical method called the SMART technique. Samadi’s SMART technique has lead thousands of men to better continence and sexual function by strategically limiting nerve damage. Apart from his extensive surgical experience, he has proven himself elite as the only urologist/oncologist to operate traditional open, minimally invasive and robotic surgeries.

Dr. Samadi has been recognized since 2008 with numerous top doctor and patient awards he has repeatedly won at least twice and as many as five times. Some in his collection are; New York Metro Area Top Doctor, Castle Colloney Top Doctors and America’s Top Doctors for Cancer. Among his patient awards are Most Compassionate doctor and Patient’s Choice.

The mega doctor is live every Sunday at 12:30 PM, New York on Dr. David Samadi TV providing valuable information for your prostate health.

Read More: www.linkedin.com/in/davidsamadi

How Dr. Dov Rand uses Bioidentical Hormones

Dr. Dov Rand is a Bioidentical Hormone Specialist who currently operates in West Orange, New Jersey. He has a board certification in the fields of repetitive and anti-aging medicine and functional medicine. Dr. Dov Rand received his medical training at the Albert Einstein Medical Center in New York, and currently practices as a doctor of physical medicine, a doctor of rehabilitation, and a psychiatrist.

Dr. Dov Rand often implements bioidentical hormones in his treatments, especially his anti-aging procedures. Bioidentical hormones are natural hormones that are created by compound pharmacists and are derived from natural sources like soy. These natural bioidentical hormones are completely identical to the naturally occurring hormones found in the human body.

Due to the compatible structure of the molecules in bioidentical hormones, they are accepted by the body when used in procedures. Because they are natural, the body does not see them as a foreign threat and implements them in healing processes says Dr. Dov.

There is another type of hormone currently in use called synthetic hormones. These hormones are mechanically altered on a molecular level, changing their entire structure. Synthetic hormones are not natural and thus are not compatible with the human body (Releasefact). Often when they are used, synthetic hormones are rejected partly or completely by the body. The rejection of synthetic hormones is just one of the many problems that can occur when they are used in anti-aging treatments.

Big pharmaceutical companies take advantage of synthetic hormones, despite their issues, because they are able to patent the chemicals. Bioidentical hormones are derived completely from natural sources, and so like other occurrences of nature, they cannot be patented (https://www.newjerseybio-identicaldoctor.com).

Because patenting medical treatments is necessary to profit from them, big pharmaceutical companies tend to overlook bioidentical hormones in favor of patented synthetic hormones. The patent process is one of the biggest separators between bioidentical hormones and synthetic hormones.

Eric Lefkofsky: An Innovator Leading The Way To A Better World

Improving by the day is the prognosis of Cancer thanks to the innovative medical advances being accomplished by companies such as Tempus, a technology company which collects clinical data and is leading the way in the field of precise medicine enabled by data collection.

Contrary to appearances, the healthcare industry lags behind as far as modern technology is concerned, and it was not until Eric Lefkofsky, founder of Tempus, saw himself dealing directly with cancer treatment by way of his wife’s cancer diagnosis that he encountered the considerable deficiencies that currently exist in the field.

While there has been ample data generated and collected about and related to patients and their respective treatments, there has never been a process to make effective and efficient use of it. With the founding of Tempus, Lefkofsky sought to reinvent the way to deliver cancer care. The company has developed an effective platform which analyzes cancer patients’ clinical and molecular data. It has also developed technology to process physician notes regarding a patient’s care; it analyzes it and structures it so that it can better help the cancer treatment and care of a patient.

With the Tempus platform and similar technology, Eric Lefkofsky and others believe that doctor will be better suited to determine which medicines and treatments are likely to be effective and which are not, thus pairing their patients with the best treatment option available. Because all information is continually updated and available at all times, healthcare professionals will be able to make decisions in real-time regarding, not only Cancer, but numerous other conditions.

Lefkofsky is a University of Michigan graduate who, apart from being the CEO and co-founder of Tempus, has co-founded numerous other companies, such as: Groupon, Echo Global Logistics, InnerWorkings, Mediaocean, Uptake.

He has also formed the Lefkofsky Foundation, a charitable trust in support of education, is on the board of directors at Children’s Memorial Hospital in Chicago, as well as the board of directors of The Art Institute of Chicago, The Museum of Science and Industry, and World Business Chicago, for which he serves as co-chairman on its Technology Council.

For details: lefkofskyfoundation.com/about-eric-lefkofsky/